Fubo L. Lu
Key Laboratory Of Urinary Tumors
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 21, 2025
Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer.
Journal: Cell death & disease
Published: July 14, 2025
The Oncopromoting Gene RBM6 Inhibits Prostate Tumour Cell Migration During Epithelial-to-Mesenchymal Transition.
Journal: Journal of cellular and molecular medicine
Published: November 29, 2024
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators.
Journal: Cell death & disease
Published: March 01, 2024
8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.
8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.
Journal: Cell death discovery
Published: September 23, 2023
PDE3B regulates KRT6B and increases the sensitivity of bladder cancer cells to copper ionophores.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 13, 2023
Langerhans cell histiocytosis with periodontal lesions as the initial manifestation: a case report
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
Published: July 06, 2018
Dentin dysplasia type I-A dental disease with genetic heterogeneity.
Journal: Oral diseases
Published: November 27, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026